Animal study · mice

Ac-SDKP cut heart rupture and aided heart function in mice after MI

Checked against the paper Animal studyPublished by PepVault

The takeaway

This adds mouse evidence that Ac-SDKP given after a heart attack reduced heart rupture and scarring and helped heart function, but it has not been shown in people.

Kind
Animal study
Studied in
Mice
Published
2019
Journal
Can J Physiol Pharmacol

What they tested

The team tested whether Ac-SDKP could cut heart rupture and harmful heart reshaping, and improve heart function, after a heart attack in mice.

How the study was done

An animal study in C57BL/6J mice that had a myocardial infarction (MI, a heart attack) and were then treated with Ac-SDKP, a daily dose of 1.6 mg/kg, over either a 1-week or a 5-week period. The team looked at inflammation, new blood vessel growth, cell death, scarring, and heart shape and function.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking Ac-SDKP? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In mice, in the first week after MI, Ac-SDKP lowered the rate of cardiac rupture, meaning the heart wall tearing. It also lowered ICAM-1 (an adhesion molecule), the number of macrophages (immune cells) moving into the heart, gelatinolytic activity, p53 and heart muscle cell death, while raising capillary density at the edge of the damaged area. Over 5 weeks, treated mice had better heart structure and function, less collagen buildup between cells, lower CHOP (a marker of endoplasmic reticulum stress), and kept their levels of SERCA2 (a calcium-handling protein in heart muscle). The authors suggest the benefit likely comes through keeping SERCA2 and blocking endoplasmic reticulum stress.

What it doesn’t show

This is mouse work, so it is not a human result. Treatment lasted at most 5 weeks, and the suggested route of action is the authors' interpretation, not something shown directly.

The paper

Peng et al. N-acetyl-seryl-aspartyl-lysyl-proline treatment protects heart against excessive myocardial injury and heart failure in mice. Can J Physiol Pharmacol. 2019.

The compound

More studies on Ac-SDKP

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking Ac-SDKP? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo